Myelopeptides
Myelopeptides has been studied in 1 paper since 1991: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 1991: “Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency”.
- 1 lab in 1 country
- Animals1
What did studies of Myelopeptides find?
3Studies of Myelopeptides measured 3 outcomes; the most studied are antibody response to SRBC (1 study), hemoglobin (1) and lifespan (1).
Antibody response to SRBC
upin mice1
1 study
Antibody response to SRBC
upin mice1
Myelopeptides improve antibody response to SRBC in mice.
“MP correct defective antibody response to SRBC in MRL/lpr mice with spontaneous autoimmune disease”
Animalsin MRL/lpr mice
Annali dell'Istituto superiore di sanita
Hemoglobin
upin mice1
1 study
Hemoglobin
upin mice1
Myelopeptides increase hemoglobin in mice.
“increase hemoglobin level in Wv/Wv mice with congenital anemia”
Animalsin Wv/Wv mice with congenital anemia
Annali dell'Istituto superiore di sanita
Lifespan
upin mice1
1 study
Lifespan
upin mice1
Myelopeptides extend lifespan in mice (2-fold).
“MP correction of immunological parameters in MRL/lpr mice resulted in 2-fold prolongation of their life span.”
Animalsin MRL/lpr mice
Annali dell'Istituto superiore di sanita